Overview Request Sample Pages Request Customization Download PDF
You are viewing: UK Dental Soft-Tissue Regeneration Market analysis

The UK Dental Soft-Tissue Regeneration Market was valued at $17.07 Million in 2024 and projected to reach to $25.57 Million by 2029, representing a compound annual growth rate of 8.4%. The UK dental soft-tissue regeneration market is experiencing significant momentum as dental practitioners embrace advanced regenerative technologies to address periodontal disease and tissue loss.

UK Dental Soft-Tissue Regeneration Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Dental Soft-Tissue Regeneration Market Trends and Insights

  • The UK market is driven by increasing demand for advanced periodontal treatments, rising awareness of minimally invasive dental procedures, and growing adoption of regenerative technologies among UK dental practitioners.
  • The UK's robust healthcare infrastructure and emphasis on preventive dentistry support market expansion throughout the forecast period. In the UK, soft-tissue regeneration solutions are gaining traction as patients and clinicians seek alternatives to traditional grafting techniques.
  • The UK market benefits from strong regulatory frameworks, high dental care standards, and increasing investment in dental research and development.
  • Between 2024 and 2029, the UK is expected to see accelerated adoption of biomaterials and scaffold-based regeneration products, driven by clinical evidence and improved reimbursement pathways.
  • The UK's aging population and rising prevalence of periodontal disease further underpin market growth..

Key Market Statistics

  • CAGR (2024-2029) 8.4% CAGR
  • Market Size, 2024 ~USD 17.07 Million
  • Forecast, 2029 ~USD 25.57 Million
  • Country UK

UK Dental Soft-Tissue Regeneration Market Overview

Market Valuation :

The UK dental soft-tissue regeneration market reached $17.07 million in 2024, with strong growth trajectory positioning it as a key segment within British dental healthcare innovation.

Growth Acceleration :

At 8.4% CAGR through 2029, the UK market outpaces the global average of 7.8%, reflecting accelerated adoption of regenerative dental technologies among UK practitioners and patients.

Clinical Demand Drivers :

UK dental professionals are increasingly adopting minimally invasive regenerative procedures, driven by patient demand for advanced periodontal treatments and tissue restoration solutions.

Forecast Growth :

The market is projected to reach $25.57 million by 2029, representing a 49.8% increase over five years, indicating robust investment and expansion opportunities in UK dental regeneration.

UK Dental Soft-Tissue Regeneration Market Dynamics

  • Growing patient awareness of minimally invasive treatment options, combined with NHS and private sector investment in modern dental solutions, is accelerating market adoption across the UK.
  • Regulatory support for innovative dental devices and increasing continuing professional development in regenerative techniques among UK dentists further strengthen market conditions.
  • The 8.4% CAGR reflects strong confidence in regenerative dentistry's clinical efficacy and commercial viability within the British healthcare landscape..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The UK dental soft-tissue regeneration market is valued at $17.07 million in 2024 and will reach $25.57 million by 2029, growing at 8.4% CAGR.
    • The UK market is propelled by rising adoption of minimally invasive regenerative procedures and strong clinical evidence supporting soft-tissue regeneration technologies.
    • The UK's aging demographic and high prevalence of periodontal disease create sustained demand for advanced soft-tissue regeneration solutions.
    • The UK's regulatory environment and reimbursement improvements are accelerating market penetration of biomaterial-based and scaffold regeneration products.

    Dental Soft-Tissue Regeneration Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment PERIODONTOLOGY (Application)
    Forecast Period 2024–2029
    Growth Rate CAGR of 7.8% from 2024 to 2029
    Largest Segment AUTOGRAFTS (Product Type)
    Market Size Base Year (Billions) ~USD 0.34 (2024)
    Revenue Forecast (Billions) ~USD 0.54 (2029)
    Segments Covered Product Type, Application, End User

    UK Dental Soft-Tissue Regeneration Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product Type

    • Autografts
    • Collagen-Based Membranes
    • Other Products
    • Synthetic Biomaterials

    By Application

    • Implantology
    • Other Applications
    • Periodontology

    By End User

    • Academic & Research Institutes
    • Dental Hospitals
    • Dsos & Independent Clinics

    UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES2.322.342.392.462.552.662.823.014.7
    DENTAL HOSPITALS8.598.849.219.6710.2310.9211.7812.856.9
    DSOS & INDEPENDENT CLINICS15.516.1817.118.219.5321.1523.1325.618.4
    TOTAL26.4127.3628.730.3332.3134.7337.7341.477.6

    Target Audience

    • Dental Device Manufacturers : UK-based and international manufacturers need market sizing and growth forecasts to develop products aligned with British practitioner needs and regulatory requirements.
    • Private Equity & Investors : Investment firms evaluating UK dental healthcare opportunities require detailed market data to assess growth potential, competitive dynamics, and ROI prospects in soft-tissue regeneration.
    • Dental Practice Operators : UK dental clinics and practice groups need market intelligence to justify investment in regenerative technologies, understand patient demand, and plan service expansion strategies.
    • Healthcare Consultants : Strategy and management consultants advising UK dental organizations require accurate market data to develop growth strategies and competitive positioning recommendations.
    • Regulatory & Policy Bodies : NHS England, NICE, and dental regulatory authorities benefit from market insights to inform healthcare policy, reimbursement decisions, and technology adoption guidelines.

    Key Companies in the UK Dental Soft-Tissue Regeneration Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEIN, INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ENVISTAUnited StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ZIMVIE INC.United StatesPrivate CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    DENTSPLY SIRONA INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ABBVIE INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ADVANCED MEDICAL SOLUTIONS GROUP PLCUnited KingdomPublic CompanyCollagen-based Membranes,Synthetic Biomaterials,Autografts,
    TISSUE REGENIXUnited KingdomPrivate CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    MECCELLIS BIOTECHFranceCollagen-based Membranes,Synthetic Biomaterials,Autografts,

    HENRY SCHEIN, INC.

    Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.

    ENVISTA

    Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.

    ZIMVIE INC.

    Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.

    DENTSPLY SIRONA INC.

    Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.

    ABBVIE INC.

    AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.

    ADVANCED MEDICAL SOLUTIONS GROUP PLC

    Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.

    TISSUE REGENIX

    Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.

    MECCELLIS BIOTECH

    Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.

    Reasons to Buy this Report

    • UK-Specific Market Intelligence : Gain detailed insights into the $17.07M UK market with precise forecasts to 2029, enabling accurate business planning and investment decisions tailored to British dental market dynamics.
    • Competitive Positioning : Understand UK practitioner adoption rates, regional demand variations, and competitive landscape to identify market entry opportunities and differentiation strategies within British dental healthcare.
    • Growth Opportunity Assessment : Leverage the 8.4% CAGR data to evaluate expansion potential, identify high-growth segments, and allocate resources effectively across UK dental markets and patient demographics.
    • Regulatory & Clinical Insights : Access UK-specific regulatory environment analysis, NHS adoption trends, and clinical practice patterns to inform product development and market strategy for British dental professionals.
    • Investment Decision Support : Make informed investment and partnership decisions with comprehensive UK market data, including growth projections, market drivers, and emerging opportunities in regenerative dentistry.

    Frequently asked questions

    What is the current size of the UK dental soft-tissue regeneration market?

    The UK dental soft-tissue regeneration market was valued at $17.07 million in 2024 and is expected to grow to $25.57 million by 2029.

    What is the growth rate of the UK dental soft-tissue regeneration market?

    The UK market is growing at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2029.

    What are the main drivers of growth in the UK market?

    Key drivers include increasing demand for minimally invasive periodontal treatments, rising clinical adoption of regenerative technologies, improved reimbursement pathways, and the UK's aging population with higher prevalence of periodontal disease.

    Which product types are leading the UK dental soft-tissue regeneration market?

    Biomaterial-based solutions and scaffold-based regeneration products are gaining significant traction in the UK market due to strong clinical evidence and regulatory support.

    How does the UK market compare to global trends?

    The UK market is growing faster than the global average, with an 8.4% CAGR compared to the global 7.8% CAGR, reflecting strong adoption of regenerative dental technologies in the UK.

    RESEARCH METHODOLOGY

    This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.

    Secondary Research

    The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.

    Primary Research

    In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.

    A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:

    Dental Soft-tissue Regeneration Market

    Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

    Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global diagnostics market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach & Top-down Approach)

    Dental Soft-tissue Regeneration Market

    Data Triangulation

    After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.

    Stakeholders

    • Dental soft-tissue regenerative material manufacturing companies
    • Distributors and suppliers of dental soft-tissue regeneration products
    • Medical device companies
    • Research and consulting firms
    • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
    • Research institutes and academic centers
    • Contract research organizations (CROs)
    • Government associations
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
    • To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
    • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
    • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
    • To analyze the generative AI impact on the dental soft-tissue regeneration market

    Get the Full Dental Soft-Tissue Regeneration Market Report

    Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status